Research & Clinical Summary

Developing safe and effective cancer immunotherapy for childhood cancer by the genetic engineering of T lymphocytes.

Interests: Cell and Gene Therapy, Tissue Injury & Regeneration

Publications

More publications associated with this author on PubMed

The following publications were retrieved from PubMed:

444Jensen, Michael

More publications associated with this author on PubMed